Announcements
- Grant of Options and PDMR Dealing
- Arecor to host company and KOL webinar today
- Positive headline results for AT278 clinical trial
- Final results for 2023
- Notice of Results
- Arecor and Medtronic Diabetes collaboration
- Publication of Full Year Financial Results delayed
- Notice of results
- BOARD CHANGE
- Arecor and TRx Biosciences research collaboration
More ▼
Key statistics
As of last trade, Arecor Therapeutics PLC (6UI:STU) traded at 1.74, 25.18% above the 52 week low of 1.39 set on Apr 17, 2024.
52-week range
Open | 1.82 |
---|---|
High | 1.82 |
Low | 1.74 |
Bid | 1.81 |
Offer | 1.94 |
Previous close | 1.75 |
Average volume | 2.22 |
---|---|
Shares outstanding | 30.63m |
Free float | 14.86m |
P/E (TTM) | -- |
Market cap | 48.54m GBP |
EPS (TTM) | -0.28 GBP |
Data delayed at least 15 minutes, as of May 23 2024.
More ▼